Runnymede Capital Advisors, Inc. Merck & Co., Inc. Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 712 shares of MRK stock, worth $61,616. This represents 0.06% of its overall portfolio holdings.
Number of Shares
712Holding current value
$61,616% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,887Shares Held
1.89BCall Options Held
15.7MPut Options Held
13.5M-
Vanguard Group Inc Valley Forge, PA251MShares$21.7 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.3 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.56 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.12 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $219B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...